Harrison St snaps up largest private life sciences portfolio in the UK

By Virna Asara 2020-01-22T00:00:00

Chicago-based alternative real estate investor Harrison Street has entered the UK biotech sector with the acquisition of a portfolio of five life sciences and innovation properties across the country for a price of around £250 mln (€300 mln).

You have now reached your article limit

Already have an IPE Real Assets account? Sign in

PropertyEU has merged with IPE Real Assets

If you had a PropertyEU account, simply reset your password to get access to IPE Real Assets.

New users can Register for free today for access to the PropertyEU Archive and IPE Real Assets.

Registration also includes access to IPE

Five reasons to register today

Access IPE Real Assets articles
Daily news alerts and updates
Track what the world’s leading institutional investors are doing
Learn about the latest industry research and market analysis
Comprehensive archive of data and intelligence on investors and fund managers, including the PropertyEU Archive

SEE HOW IPE REAL ASSETS CAN HELP YOUR business